MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study
Journal of Clinical Microbiology · 20.04.2023 · 61 (4)
DOI: 10.1128/jcm.01626-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 20.04.2023. Verfasst von Kiyoharu Fukushima und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan. Hauptthemen laut MEDLINE: Nontuberculous Mycobacteria, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, GlaxoSmithKline, MEXT | Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Because nontuberculous mycobacterial pulmonary disease is a considerable health burden, a simple and clinically applicable analytical protocol enabling the identification of subspecies and drug-resistant disease is required to determine the treatment strategy. We aimed to develop a simplified workflow consisting only of direct sequencing of mycobacterial growth indicator tube cultures (MGIT-seq).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
- Department of Host Defense, Research Institute for Microbial Diseases (RIMD), Osaka University, Osaka, Japan.
- Laboratory of Host Defense, World Premier Institute Immunology Frontier Research Center (WPI-IFReC), Osaka University, Osaka, Japan.
- Global Center for Medical Engineering and Informatics, Suita, Osaka, Japan.
- Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), Osaka University, Suita, Osaka, Japan.
ORCID-Profile: Kiyoharu Fukushima, Hiroshi Kida
Förderung
- Japan Agency for Medical Research and Development
- GlaxoSmithKline
- MEXT | Japan Society for the Promotion of Science
- Takeda Science Foundation
- Foundation of Kinoshita Memorial Enterprise
- Uehara Memorial Foundation
- MSD Life Science Foundation, Public Interest Incorporated Foundation
- Japan Intractable Diseases Research Foundation
Zitieren
APA
Fukushima, K., Matsumoto, Y., Matsuki, T., Saito, H., Motooka, D., Komukai, S., Fukui, E., Yamuchi, J., Nitta, T., Niitsu, T., Abe, Y., Nabeshima, H., Nagahama, Y., Nii, T., Tsujino, K., Miki, K., Kitada, S., Kumanogoh, A., Akira, S., …, & Kida, H. (2023). MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study. Journal of Clinical Microbiology, 61(4). https://doi.org/10.1128/jcm.01626-22
Vancouver
Fukushima K, Matsumoto Y, Matsuki T, Saito H, Motooka D, Komukai S, et al. MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study. Journal of Clinical Microbiology. 2023;61(4). doi:10.1128/jcm.01626-22
BibTeX
@article{Fukushima2023,
author = {Fukushima, Kiyoharu and Matsumoto, Yuki and Matsuki, Takanori and Saito, Haruko and Motooka, Daisuke and Komukai, Sho and Fukui, Eriko and Yamuchi, June and Nitta, Tadayoshi and Niitsu, Takayuki and Abe, Yuko and Nabeshima, Hiroshi and Nagahama, Yasuharu and Nii, Takuro and Tsujino, Kazuyuki and Miki, Keisuke and Kitada, Seigo and Kumanogoh, Atsushi and Akira, Shizuo and Nakamura, Shota and Kida, Hiroshi},
title = {MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study},
journal = {Journal of Clinical Microbiology},
year = {2023},
volume = {61},
number = {4},
doi = {10.1128/jcm.01626-22}
}
EUVIMED